Insulinoma historical perspective

Revision as of 19:54, 21 August 2017 by Amandeep Singh (talk | contribs)
Jump to navigation Jump to search

Insulinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Insulinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Insulinoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Insulinoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Insulinoma historical perspective

CDC on Insulinoma historical perspective

Insulinoma historical perspective in the news

Blogs on Insulinoma historical perspective

Directions to Hospitals Treating Insulinoma

Risk calculators and risk factors for Insulinoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]Amandeep Singh M.D.[3]

Overview

Pancreatic islet cells were first described by Paul Langerhans in 1869, while he was still a medical student. Insulin was first discovered by Frederick Banting and Charles Best in 1922 from a dog’s pancreas. In 1927, William J Mayo was the first to discover the association between hyperinsulinism and a functional pancreatic islet cell tumor. In 1929, Roscoe Graham was the first to perform surgical cure of an islet cell tumor.

Historical Perspective

  • Pancreatic islet cells were first described by Paul Langerhans in 1869, while he was still a medical student.
  • Insulin was first discovered by Frederick Banting and Charles Best in 1922 from a dog’s pancreas.
  • In 1927, William J Mayo was the first to discover the association between hyperinsulinism and a functional pancreatic islet cell tumor.
  • In 1929, Roscoe Graham was the first to perform surgical cure of an islet cell tumor.[1]
  • Hypoglycemia was first recognized in the 19th century. In the 1920s, after the discovery of insulin and its use in the treatment of diabetics, hyperinsulinism was suspected to be a cause of hypoglycemia in non-diabetics.[2]
  • A pioneering description of hyperinsulinism as a cause of hypoglycemia was published by Seale Harris in 1924.[2]
  • The first report of a surgical cure of hypoglycemia by removing an islet cell tumour was in 1929.

Overview

Historical Perspective

Discovery

  • In 1902, the first of adenoma of pancreatic islets was discovered by Nicholls.[3]
  • In 1927 the insulinoma was first described in Mayo clinic which was dissected in 1929 in Toronto.[3]
  • [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
  • The association between hyperinsulinism and functional islet tumor was made in 1926 by Wilder-et-al after a surgery on a person who had hypoglycemia and found a n islet cell cancer with liver metastasis.[4]
  • In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
  • In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

Landmark Events in the Development of Treatment Strategies

  • In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

Famous Cases

References

  1. Murray PD, McKenzie DT, Swain SL, Kagnoff MF (1987). "Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression". J Immunol. 139 (8): 2669–74. PMID 3498768.
  2. 2.0 2.1 Insulinoma. Wikipedia. https://en.wikipedia.org/wiki/Insulinoma. Accessed on October 5,2015
  3. 3.0 3.1 Stamatakos M, Safioleas C, Tsaknaki S, Safioleas P, Iannescu R, Safioleas M (2009). "Insulinoma: a rare neuroendocrine pancreatic tumor". Chirurgia (Bucur). 104 (6): 669–73. PMID 20187464.
  4. Wilder, Russell M.; Allan, Frank N.; Power, M. H.; Robertson, H. E. (1927). "CARCINOMA OF THE ISLANDS OF THE PANCREAS". Journal of the American Medical Association. 89 (5): 348. doi:10.1001/jama.1927.02690050014007. ISSN 0002-9955.

Template:WH Template:WS